GDP	O
and	O
AGE	O
receptors	O
:	O
mechanisms	O
of	O
peritoneal	B-Multi-tissue_structure
damage	O
.	O

Long	O
-	O
term	O
peritoneal	B-Multi-tissue_structure
dialysis	O
(	O
PD	O
)	O
is	O
limited	O
by	O
morphological	O
changes	O
of	O
the	O
peritoneal	B-Multi-tissue_structure
membrane	I-Multi-tissue_structure
.	O

Structural	O
changes	O
were	O
promoted	O
by	O
toxicity	O
of	O
glucose	O
degradation	O
products	O
(	O
GDPs	O
)	O
which	O
are	O
generated	O
during	O
heat	O
sterilization	O
in	O
peritoneal	B-Multi-tissue_structure
dialysis	O
fluids	O
(	O
PDFs	O
)	O
.	O

Besides	O
their	O
direct	O
toxicity	O
GDPs	O
promote	O
formation	O
of	O
advanced	O
glycation	O
endproducts	O
(	O
AGEs	O
)	O
.	O

RAGE	O
(	O
receptor	O
for	O
AGE	O
)	O
is	O
the	O
best	O
characterized	O
signal	O
transduction	O
receptor	O
for	O
AGEs	O
and	O
is	O
expressed	O
on	O
mesothelial	B-Cell
cells	I-Cell
.	O

The	O
effects	O
of	O
PDFs	O
with	O
different	O
amounts	O
of	O
GDPs	O
were	O
compared	O
on	O
morphological	O
changes	O
in	O
the	O
peritoneal	B-Multi-tissue_structure
membrane	I-Multi-tissue_structure
in	O
a	O
RAGE	O
-	O
/	O
-	O
mouse	O
model	O
.	O

It	O
could	O
be	O
demonstrated	O
that	O
RAGE	O
plays	O
a	O
pivotal	O
role	O
in	O
structural	O
damage	O
(	O
e	O
.	O
g	O
.	O
inflammation	O
,	O
neoangiogenesis	O
and	O
fibrosis	O
)	O
of	O
the	O
peritoneal	B-Multi-tissue_structure
membrane	I-Multi-tissue_structure
.	O

Further	O
investigations	O
of	O
this	O
pathway	O
with	O
regard	O
to	O
preventing	O
peritoneal	B-Multi-tissue_structure
fibrosis	O
should	O
be	O
performed	O
to	O
maintain	O
the	O
integrity	O
of	O
the	O
peritoneal	B-Multi-tissue_structure
membrane	I-Multi-tissue_structure
in	O
peritoneal	B-Multi-tissue_structure
dialysis	O
patients	O
.	O

